CAH - 21-Hydroxylase Deficiency

Explore clinical trials studying CAH - 21-Hydroxylase Deficiency. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

CAH - 21-Hydroxylase Deficiency trial results

Recruiting

NCT06900153

Conditions: Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +16 more
Locations: Hospices Civiles de Lyon - Hôpital Femme Mère Enfant, Service Endocrinologie Bron, France

AP-HP Hôpital Bicêtre, Service Endocrinologie Le Kremlin-Bicêtre, France

Service d'endocrinologie, Hôpital Pitié Salpêtrière Paris, France

Service d'endocrinologie, Hôpital Saint Antoine Paris, France

Completed

NCT03687242

Conditions: Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +18 more
Locations: Spruce Biosciences Clinical Site Orange, California, United States

Spruce Biosciences Clinical Site San Diego, California, United States

Spruce Biosciences Clinical Site Atlanta, Georgia, United States

Spruce Biosciences Clinical Site Indianapolis, Indiana, United States